Patents by Inventor Mark Glassy

Mark Glassy has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Therapeutic Use Of Rm1 Antigen
    Publication number: 20070280879
    Abstract: The antigen recognized by RM1 antibody is used for therapy, diagnosis and imaging.
    Type: Application
    Filed: March 11, 2005
    Publication date: December 6, 2007
    Applicant: Shantha West, Inc.
    Inventors: Mark Glassy, Michael McKnight, Sonjoy Mukerjee, Subhra Chakrabarti
  • AgRM2 antigen
    Publication number: 20070248539
    Abstract: The antigen recognized by the antibody produced by a deposited cell line (ATCC accession no. PTA 5411) has been shown to be a fragment of vimentin. This vimentin fragment will be useful in therapy of and screening for cell proliferative disorders such as cancer.
    Type: Application
    Filed: April 23, 2007
    Publication date: October 25, 2007
    Applicant: Shantha West Inc.
    Inventors: Mark Glassy, Michael McKnight
  • Antibodies That Recognize Hyperproliferative Cells and Methods of Making and Using Same
    Publication number: 20070092443
    Abstract: The invention relates to antibodies that bind to antigens, such as antigens associated with hyperproliferating cells, and methods of treating hyperproliferative disorders. The invention antibodies are useful for treating hyperproliferative disorders, such as neoplasia.
    Type: Application
    Filed: December 6, 2006
    Publication date: April 26, 2007
    Applicant: SHANTHA WEST, INC.
    Inventors: Subhra Chakrabarti, Sonjoy Mukerjee, Mark Glassy
  • Antibodies that recognize hyperproliferative cells and methods of making and using same
    Publication number: 20050031621
    Abstract: The invention relates to antibodies that bind to antigens, such as antigens associated with hyperproliferating cells, and methods of treating hyperproliferative disorders. The invention antibodies are useful for treating hyperproliferative disorders, such as neoplasia.
    Type: Application
    Filed: September 11, 2003
    Publication date: February 10, 2005
    Inventors: Subhra Chakrabarti, Sonjoy Mukerjee, Mark Glassy